Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Xtant Medical Holdings, Inc. (XTNT) had Revenue of $117.27M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$117.27M
Net Income	$-16.45M
Cost of Goods Sold	$49.05M
Gross Profit	$68.22M
Operating Expenses	$129.34M
Operating Income	$-12.07M
Non-Operating Income/Expense	$-4.19M
Pre-Tax Income	$-16.26M
Normalized Pre-Tax Income	$-16.26M
Income after Taxes	$-16.45M
Income from Continuous Operations	$-16.45M
Consolidated Net Income/Loss	$-16.45M
Normalized Income after Taxes	$-16.45M
EBIT	$-12.07M
EBITDA	$-7.85M
Weighted-Average Shares Outstanding (Basic)	133.66M
Weighted-Average Shares Outstanding (Diluted)	133.66M
Earnings per Share (EPS) (Basic)	$-0.12
Earnings per Share (EPS) (Diluted)	$-0.12
Balance Sheet Financials
Current Assets	$67.12M
Property, Plant, and Equipment	$10.13M
Long-Term Assets	$26.72M
Total Assets	$93.84M
Current Liabilities	$28.58M
Long-Term Debt	$22.09M
Long-Term Liabilities	$22.29M
Total Liabilities	$50.87M
Common Equity	$42.96M
Tangible Shareholders Equity	$27.30M
Shareholders Equity	$42.96M
Common Shares Outstanding	139.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-11.90M
Cash Flow from Investing Activities	$-3.73M
Cash Flow from Financial Activities	$16.07M
Beginning Cash	$5.92M
End Cash	$6.22M
Increase/Decrease in Cash	$0.30M
Stock-Based Compensation	$4.12M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.35
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.34
Debt to Equity Ratio	0.80
Gross Margin	58.17%
Operating Margin	-10.30%
EBIT Margin	-10.30%
EBITDA Margin	-6.69%
Pre-Tax Profit Margin	-13.87%
Profit Margin	-14.03%
Free Cash Flow	$-15.63M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.25
Inventory Turnover	1.27
Receiveable Turnover	5.68
Days Sales in Receivables	64.31
Return on Equity	-38.29%
Return on Tangible Equity	-60.24%
Return on Assets	-17.53%
Return on Investments	-25.29%
Book Value Per Share	$0.31
Free Cash Flow per Share	$-0.12
Operating Cash Flow per Share	$-0.09

Data from Zacks Investment Research, Inc.